دورية أكاديمية
أعرض في EDS

An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals.

التفاصيل البيبلوغرافية
العنوان: An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals.
المؤلفون: Gülhan PY; Department of Chest Diseases, Duzce University Faculty of Medicine, Duzce, Turkey. Electronic address: pinaryildiz691@hotmail.com., Arbak PM; Department of Chest Diseases, Duzce University Faculty of Medicine, Duzce, Turkey., Annakkaya AN; Department of Chest Diseases, Duzce University Faculty of Medicine, Duzce, Turkey., Balbay EG; Department of Chest Diseases, Duzce University Faculty of Medicine, Duzce, Turkey., Balbay ÖA; Department of Chest Diseases, Duzce University Faculty of Medicine, Duzce, Turkey.
المصدر: American journal of infection control [Am J Infect Control] 2022 Oct; Vol. 50 (10), pp. 1125-1132. Date of Electronic Publication: 2022 Jul 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 8004854 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3296 (Electronic) Linking ISSN: 01966553 NLM ISO Abbreviation: Am J Infect Control Subsets: MEDLINE
أسماء مطبوعة: Original Publication: St. Louis, Mosby
مواضيع طبية MeSH: COVID-19* , Pulmonary Disease, Chronic Obstructive*, Adult ; Carbon Monoxide/physiology ; Delivery of Health Care ; Dyspnea/etiology ; Female ; Humans ; Lung ; Male ; Middle Aged ; Pain ; Pulmonary Diffusing Capacity/physiology
مستخلص: Background: The medium- and long-term effects of COVID-19 infection on pulmonary function are still unknown. The present study aimed to investigate the pulmonary functions in healthcare professionals who had persistent complaints after contracting COVID-19 and returning to work.
Methods: The study included COVID-19-infected healthcare professionals from the Düzce University Medical Faculty Hospital who volunteered to participate. Medical histories, medical records, pulmonary function tests, the diffusing capacity of the lungs for carbon monoxide (DLCO) test, and the 6-minute walk test (6MWT) were used to collect data from all participants.
Results: The study included 53 healthcare professionals, with an average age of 38 ± 10 years (min: 24 years and max: 71 years), including 29 female (54.7%) and 24 male (45.3%) participants. Of the participants, 22.6% were smokers, 35.8% (19 individuals) had comorbidities, and 17% (9 individuals) were hospitalized. The mean length of stay was 9 ± 4 days (mean ± standard deviation). The most prevalent symptoms were weakness (88.7%), muscle aches (67.9%), inability to smell/taste (60.4%), headache (54.7%), fever (45.3%), cough (41.5%), and shortness of breath (37.7%). The mean time to return to work after a positive polymerase chain reaction (PCR) test for COVID-19 was 18 ± 13 days. The average time among post-disease pulmonary function, 6MW, and DLCO tests was 89 ± 36 days (min: 15 and max: 205). The DLCO level decreased in 39.6% (21) of the participants. Female participants had a significantly higher rate of decreased DLCO levels than male participants (25% vs. 55.2%, P = .026). DLCO levels were significantly higher in participants with long-term persistent complaints (P = .043). The later the time to return to work, the lower the DLCO value (r = -0.290 and P = .035). The 6MWT distance was positively correlated with hemoglobin and lymphocyte levels at the time of the disease onset and negatively correlated with D-dimer levels. The most prevalent symptoms during the control visits were shortness of breath/effort dyspnea (24.6%), weakness (9.5%), and muscle aches (7.6%).
Conclusion: Significant persistent complaints (47.2%) and low DLCO levels (39.6%) were observed in healthcare professionals during control visits at a mean time of 3 months after the COVID-19 infection. Symptoms and spirometry measurements, including DLCO, may be helpful in the follow-up of healthcare professionals who contracted COVID-19. Further comprehensive studies with long-term follow-up periods are required.
(Copyright © 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.)
References: BMJ. 2020 Jul 14;370:m2815. (PMID: 32665317)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
JACC Cardiovasc Imaging. 2021 Nov;14(11):2155-2166. (PMID: 33975819)
EClinicalMedicine. 2020 Aug;25:100463. (PMID: 32838236)
Nat Med. 2020 May;26(5):639. (PMID: 32350461)
Eur Respir J. 2021 Apr 29;57(4):. (PMID: 33419891)
Lancet Respir Med. 2021 Jul;9(7):747-754. (PMID: 33964245)
Medicine (Baltimore). 2020 Jul 24;99(30):e21396. (PMID: 32791752)
J Korean Med Sci. 2020 Dec 07;35(47):e418. (PMID: 33289374)
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. (PMID: 31613151)
Rev Cardiovasc Med. 2022 Feb 9;23(2):53. (PMID: 35229544)
Indian J Palliat Care. 2021 Apr-Jun;27(2):313-318. (PMID: 34511802)
BMC Infect Dis. 2021 Nov 24;21(1):1183. (PMID: 34819019)
Respirology. 2010 Apr;15(3):543-50. (PMID: 20337995)
فهرسة مساهمة: Keywords: 6-minute walk test; COVID-19 infection; Diffusing capacity of the lungs for carbon monoxide; Healthcare professional; Pulmonary function tests
المشرفين على المادة: 7U1EE4V452 (Carbon Monoxide)
تواريخ الأحداث: Date Created: 20220723 Date Completed: 20220928 Latest Revision: 20230124
رمز التحديث: 20230126
مُعرف محوري في PubMed: PMC9296374
DOI: 10.1016/j.ajic.2022.07.003
PMID: 35870662
قاعدة البيانات: MEDLINE
الوصف
تدمد:1527-3296
DOI:10.1016/j.ajic.2022.07.003